Drug Discovery for Schizophrenia (RSC Drug Discovery) 2015(1).pdf

(3954 KB) Pobierz
10:30:15.
Published on 28 April 2015 on http://pubs.rsc.org | doi:10.1039/9781782622499-FP001
Drug Discovery for Schizophrenia
View Online
RSC Drug Discovery Series
Editor-in-Chief:
10:30:15.
Published on 28 April 2015 on http://pubs.rsc.org | doi:10.1039/9781782622499-FP001
Professor David Thurston,
King’s College, London, UK
Series Editors:
Professor David Rotella,
Montclair State University, USA
Professor Ana Martinez,
Centro de Investigaciones Biologicas-CSIC, Madrid, Spain
Dr David Fox,
Vulpine Science and Learning, UK
Advisor to the Board:
Titles in the Series:
Professor Robin Ganellin,
University College London, UK
1: Metabolism, Pharmacokinetics and Toxicity of Functional Groups
2: Emerging Drugs and Targets for Alzheimer’s Disease; Volume 1
3: Emerging Drugs and Targets for Alzheimer’s Disease; Volume 2
4: Accounts in Drug Discovery
5: New Frontiers in Chemical Biology
6: Animal Models for Neurodegenerative Disease
7: Neurodegeneration
8: G Protein-Coupled Receptors
9: Pharmaceutical Process Development
10: Extracellular and Intracellular Signaling
11: New Synthetic Technologies in Medicinal Chemistry
12: New Horizons in Predictive Toxicology
13: Drug Design Strategies: Quantitative Approaches
14: Neglected Diseases and Drug Discovery
15: Biomedical Imaging
16: Pharmaceutical Salts and Cocrystals
17: Polyamine Drug Discovery
18: Proteinases as Drug Targets
19: Kinase Drug Discovery
20: Drug Design Strategies: Computational Techniques and Applications
21: Designing Multi-Target Drugs
22: Nanostructured Biomaterials for Overcoming Biological Barriers
23: Physico-Chemical and Computational Approaches to Drug Discovery
24: Biomarkers for Traumatic Brain Injury
25: Drug Discovery from Natural Products
26: Anti-Inflammatory Drug Discovery
27: New Therapeutic Strategies for Type 2 Diabetes: Small Molecules
28: Drug Discovery for Psychiatric Disorders
29: Organic Chemistry of Drug Degradation
30: Computational Approaches to Nuclear Receptors
31: Traditional Chinese Medicine
32: Successful Strategies for the Discovery of Antiviral Drugs
View Online
10:30:15.
Published on 28 April 2015 on http://pubs.rsc.org | doi:10.1039/9781782622499-FP001
33: Comprehensive Biomarker Discovery and Validation for Clinical
Application
34: Emerging Drugs and Targets for Parkinson’s Disease
35: Pain Therapeutics; Current and Future Treatment Paradigms
36: Biotherapeutics: Recent Developments using Chemical and Molecular
Biology
37: Inhibitors of Molecular Chaperones as Therapeutic Agents
38: Orphan Drugs and Rare Diseases
39: Ion Channel Drug Discovery
40: Macrocycles in Drug Discovery
41: Human-based Systems for Translational Research
42: Venoms to Drugs: Venom as a Source for the Development of Human
Therapeutics
43: Carbohydrates in Drug Design and Discovery
44: Drug Discovery for Schizophrenia
How to obtain future titles on publication:
A standing order plan is available for this series. A standing order will bring
delivery of each new volume immediately on publication.
For further information please contact:
Book Sales Department, Royal Society of Chemistry, Thomas Graham
House, Science Park, Milton Road, Cambridge, CB4 0WF, UK
Telephone: +44 (0)1223 420066, Fax: +44 (0)1223 420247,
Email: booksales@rsc.org
Visit our website at www.rsc.org/books
10:30:15.
Published on 28 April 2015 on http://pubs.rsc.org | doi:10.1039/9781782622499-FP001
View Online
View Online
Drug Discovery for
Schizophrenia
10:30:15.
Published on 28 April 2015 on http://pubs.rsc.org | doi:10.1039/9781782622499-FP001
Edited by
Tatiana V. Lipina
Institute of Physiology, Novosibirsk, Russia
Email: lipina@physiol.ru
John C. Roder
Lunenfeld–Tanenbaum Research Institute, Toronto, Canada
Email: roder@lunenfeld.ca

Plik z chomika:

Inne pliki z tego folderu:

Inne foldery tego chomika:

Zgłoś jeśli naruszono regulamin